Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

BACKGROUND: Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on corticosteroids and/or immunomodulators. However, response to th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Torrisi, Sebastiano Emanuele, Kahn, Nicolas, Wälscher, Julia, Sarmand, Nilab, Polke, Markus, Lars, Kehler, Eichinger, Monika, Heussel, Claus Peter, Palmucci, Stefano, Sambataro, Francesca Maria, Sambataro, Gianluca, Sambataro, Domenico, Vancheri, Carlo, Kreuter, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852748/
https://ncbi.nlm.nih.gov/pubmed/31718637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0937-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados